IOL Chemicals and Pharmaceuticals Ltd

Stage 2 · Advancing · week 21Setup 6.2 ★ FairEven -0.1

As of 16 Oct 2026, IOL Chemicals and Pharmaceuticals is in Stage 2 — advancing, the uptrend phase, in week 21 (since 25 May 2026). It closed at ₹195, 11.6% below its 52-week high and above its 200-day average, which is rising. In Materials, 33.6% of stocks are in Stage 2.

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. More about the company

₹194.7
-0.20% today
₹5,715 Cr · Mid cap
Market Neutral — FadingMaterials 33.6% in Stage 2-2.9 pts / 20dCommodity Chemicals 48.5%-4.5 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

6.2 ★ Fair

Momentum

Steady

Edge

Even -0.1

Setup-score rank among Stage 2 peers: #11 of 32 in Commodity Chemicals · #50 of 153 in Materials

Is IOLCP early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-11.6%
₹68.1 lo₹220.2 hi
11.6% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 21
1w13w26w
Week 21 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
56.2%
200 DMA: ₹124.7 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.44x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
MA20 gently rising · +0.7% vs MA50 +11.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+0.1%
3M
+31.3%
6M
+127.5%
YTD
+138.0%
1Y
+92.1%
Sector
Materials
↓ Peaking
Stage 2%
33.6%
20d Δ
-2.9pp
1M return
-1.6%
3M return
-2.6%
Sector Stage-2 % · last 20 days
This stock ranks #19 of 151 Stage 2 stocks in Materials by RS. Leading the sector.
Industry
Commodity Chemicals
↓ Peaking
Stage 2%
48.5%
20d Δ
-4.5pp
1M return
+3.0%
3M return
+2.5%
Industry Stage-2 % · last 20 days
Ranks #5 of 32 Stage 2 stocks in this industry. Top tier.
Stage Cycle Timeline2023-07-20 → 2026-10-16
S4 15w
S4 13w
S2 20w
S4 14w
S2 21w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S3 8w → S2 11w → S3 5w → S2 5w → S3 4w → S4 15w → S1 8w → S2 10w → S3 4w → S4 7w → S1 3w → S4 13w → S1 5w → S2 20w → S3 8w → S4 14w → S1 5w → S2 21w current
Total tracked: 168 weeks across 18 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-16
Pullback Hunter
Latest: 2026-10-08
60 appearances in last 60 days. First seen: 2026-08-14.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 21 · Vol 0.44x
2026-10-15S2
Wk 21 · Vol 0.32x
2026-10-14S2
Wk 21 · Vol 0.55x
2026-10-13S2
Wk 20 · Vol 0.60x
2026-10-12S2
Wk 20 · Vol 0.41x
2026-10-09S2
Wk 20 · Vol 0.66x
2026-10-08S2
Wk 20 · Vol 1.01x
2026-10-07S2
Wk 20 · Vol 1.58x
2026-10-06S2
Wk 19 · Vol 0.98x
2026-10-05S2
Wk 19 · Vol 0.74x
2026-10-01S2
Wk 19 · Vol 1.03x
2026-09-30S2
Wk 19 · Vol 0.87x
Sector Peers — Stage 2All →
OCCLLTD
wk 17 · -16.3% from hi
9.0
MUKANDLTD
wk 21 · -7.5% from hi
8.9
SUNFLAG
wk 3 · -9.3% from hi
8.8
CUBEXTUB
wk 2 · 0.0% from hi
8.7
NRL
wk 17 · 0.0% from hi
8.6
Moving averages & range
50 DMA
₹190.5
200 DMA
₹124.7
52W High
₹220.2
52W Low
₹68.1
5D Low
₹194.7
Resistance levels (recent highs)
20d High
₹220.2
60d High
₹220.2
120d High
₹220.2
250d High
₹220.2
Next resistance
+13.1%
to 20d High
Ask the Market AI about IOLCPAsk →
P/E (TTM)
28.0
Forward 16.2
Earnings Growth (YoY)
+69.7%
Revenue +17.4%
ROE
+7.9%
Profit margin +5.9%
Dividend Yield
0.73%
P/B 2.2
About this companyMaterials· Commodity Chemicals

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.